Financial Performance - The company's operating revenue for 2023 was ¥88,040,600.80, a decrease of 90.06% compared to ¥885,746,851.76 in 2022[21]. - The net profit attributable to shareholders for 2023 was -¥120,115,833.29, representing a decline of 151.72% from ¥232,296,378.74 in 2022[21]. - The net cash flow from operating activities was -¥52,224,007.16, a decrease of 349.87% compared to ¥20,900,600.38 in 2022[21]. - The total assets at the end of 2023 were ¥1,192,593,505.11, down 11.26% from ¥1,343,332,102.28 at the end of 2022[23]. - The net assets attributable to shareholders decreased by 10.03% to ¥1,031,077,872.65 in 2023 from ¥1,146,062,191.42 in 2022[23]. - The company reported a significant decline in the average asset-liability ratio of listed breeding companies to 62.28% as of Q3 2023, indicating financial stress in the industry[32]. - The company's total operating cost for 2023 was ¥51,399,399.88, a decrease of 93.57% from ¥799,824,788.78 in 2022[45]. - The company reported a significant decline in direct exports, which fell to ¥1,301,190.78, a decrease of 99.06% compared to ¥138,348,840.71 in the previous year[41]. - The company reported a loss of approximately CNY 14.80 million from projects in the new energy sector due to significant uncertainties[39]. - The company achieved a return of approximately CNY 20.41 million from prudent cash management and investment strategies during the reporting period[39]. Business Strategy and Focus - The main business focus has shifted to veterinary vaccines, following the strategic exit from the fine enameled wire business in Q3 2022[18]. - The main business focus remains on veterinary vaccines, particularly for pigs, with six core products and five professional services offered[33]. - The company is enhancing its R&D capabilities through collaborations with renowned institutions, focusing on various types of vaccines including inactivated and genetically engineered vaccines[33]. - The company has implemented a flexible procurement strategy to reduce costs while ensuring quality stability[33]. - The company is committed to a diversified strategy to enhance its risk resilience and balance its operational risks[39]. - The company aims to diversify its business and enhance its sustainable operational capabilities by exploring new growth points[73]. Internal Controls and Compliance - The company reported a significant issue with its subsidiary, Shiji Biological, involving improper revenue recognition, which led to a major defect in the internal control system of the financial report[3]. - The internal control system has been updated and improved, effectively preventing operational risks and ensuring the achievement of internal control objectives[113]. - The company has completed the correction of accounting errors caused by improper application of accounting policies by subsidiaries, which did not affect the annual financial report data[114]. - The internal control audit report issued a negative opinion, indicating that the company failed to maintain effective financial reporting internal controls as of December 31, 2023[118]. - The company’s management acknowledged that the identified defects represent clear violations of accounting standards and related disclosure regulations[120]. - The company’s management has developed corrective measures in response to the identified deficiencies in internal controls[120]. Shareholder and Governance - The company plans not to distribute cash dividends, issue bonus shares, or increase share capital from reserves[4]. - The company has a three-year shareholder return plan (2021-2023) but did not meet the conditions for profit distribution during the reporting period[109]. - The company has established a governance structure that complies with relevant laws and regulations, ensuring no significant discrepancies with the requirements of the CSRC and Shenzhen Stock Exchange[80]. - The board of directors consists of 7 members, including 3 independent directors, meeting the legal requirements for composition[81]. - The company has a diverse management team with backgrounds in finance, accounting, and corporate governance[91]. - The company has not proposed any cash dividend distribution plan for the reporting period, as the undistributed profits in the consolidated financial statements are negative[111]. Environmental Responsibility - The company has implemented effective pollution control measures, with no instances of exceeding emission standards reported throughout the year[123]. - The wastewater treatment facility has a capacity of 700 m³/d, ensuring compliance with discharge standards[124]. - The company has established an emergency response plan for environmental incidents, valid from July 2022 to July 2025[125]. - The company received no administrative penalties related to environmental issues during the reporting period[126]. - The company emphasizes its commitment to corporate social responsibility, focusing on environmental protection and stakeholder rights[128]. Market Conditions and Competition - The overall market for veterinary vaccines is facing intense competition due to a supply-demand imbalance in the pig farming industry[32]. - The company faced significant operational pressure due to a prolonged downturn in the pig farming industry, leading to intensified price competition in the veterinary vaccine sector, resulting in a decline in product gross margins[34]. - The company is facing significant market competition in the veterinary vaccine business, with pressures from low pig prices and rising breeding costs[76]. Research and Development - The company has established a comprehensive R&D platform with multiple specialized laboratories and has obtained 24 authorized patents, including 17 invention patents and 7 utility model patents[35]. - The number of R&D personnel increased by 7.32% to 44 in 2023, with a higher proportion of bachelor's degree holders[51]. - R&D investment as a percentage of operating income rose to 13.72% in 2023 from 6.68% in 2022[51]. Financial Management - The financial department operates independently, with a strict accounting system and independent bank accounts, ensuring no interference from the controlling shareholder[83]. - The company has entrusted 10 million yuan in bank wealth management products and 48.37 million yuan in broker wealth management products, with a total of 93.37 million yuan in entrusted wealth management[174]. - The company reported a total of 76,575.47 million yuan in entrusted financial management, with an actual income of 1,816.03 million yuan during the reporting period[176]. Related Party Transactions - The company has established a system to manage related transactions, ensuring they are conducted at fair market prices to protect shareholder interests[135]. - The company reported no non-operating fund occupation by controlling shareholders or related parties during the reporting period[147]. - There were no violations regarding external guarantees during the reporting period[148].

关于贤丰控股股份有限公司 二○二三年度审计报告 非标意见的专项说明 关于贤丰控股股份有限公司 2023 年度审计报告无保留意见审计报告中 强调事项段涉及事项的专项说明 （2024）京会兴专字第 00440003 号 贤丰控股股份有限公司全体股东： 我们接受委托，审计了贤丰控股股份有限公司（以下简称"贤丰控股公司"） 2023 年度财务报表，包括 2023 年 12 月 31 日的合并及母公司资产负债表，2023 年度的合并及母公司利润表、合并及母公司现金流量表、合并及母公司股东权益 变动表以及财务报表附注，并出具了带强调事项段的无保留意见审计报告(（2024） 京会兴审字第 00440003 号)。 根据中国证券监督管理委员会《公开发行证券的公司信息披露编报规则第14 号--非标准审计意见及其涉及事项的处理》、《监管规则适用指引--审计类第 1 号》 及《深圳证券交易所股票上市规则》的相关要求，现就相关事项说明如下: 一、强调事项段涉及的事项 (一)审计报告中与强调段中的内容 1、我们提醒财务报表使用者关注，如财务报表附注十四、（二）1 所述，由 于控股股东贤丰控股集团有限公司及其一致行动人广东贤丰控股有限公 ...

证券代码：002141 证券简称：贤丰控股 公告编号：2024-031 贤丰控股股份有限公司 关于召开 2023 年年度股东大会的通知 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 贤丰控股股份有限公司(以下简称"公司"或"上市公司")第八届董事会第 五次会议审议通过了《关于召开 2023 年年度股东大会的议案》，决定于 2024 年 5 月 16 日召开公司 2023 年年度股东大会，审议董事会、监事会提交的相关议案， 现将本次会议的有关事项通知如下： 一、召开会议的基本情况 1.股东大会届次：2023 年年度股东大会。 2.股东大会的召集人：公司董事会。 3.会议召开的合法、合规性：本次股东大会会议的召集、召开符合有关法律、 行政法规、部门规章、规范性文件和《公司章程》的规定。 4.会议召开的日期、时间： (1)现场会议召开时间：2024 年 5 月 16 日 15:00。 (2)网络投票时间为：2024 年 5 月 16 日。其中：通过深圳证券交易所交易 系统进行网络投票的具体时间为 2024 年 5 月 16 日 9:15-9:25、9:30-11: ...

贤丰控股股份有限公司 2023年度内部控制自我评价报告 贤丰控股股份有限公司全体股东： 根据《企业内部控制基本规范》及其配套指引的规定和其他内部控制监管要 求（以下简称企业内部控制规范体系），结合本公司（以下简称公司）内部控制 制度和评价办法，在内部控制日常监督和专项监督的基础上，我们对公司2023 年12月31日（内部控制评价报告基准日）的内部控制有效性进行了评价。 一、重要声明 按照企业内部控制规范体系的规定，建立健全和有效实施内部控制，评价其 有效性，并如实披露内部控制评价报告是公司董事会的责任。监事会对董事会建 立和实施内部控制进行监督。经理层负责组织领导企业内部控制的日常运行。公 司董事会、监事会及董事、监事、高级管理人员保证本报告内容不存在任何虚假 记载、误导性陈述或重大遗漏，并对报告内容的真实性、准确性和完整性承担个 别及连带法律责任。 公司内部控制的目标是合理保证经营管理合法合规、资产安全、财务报告及 相关信息真实完整，提高经营效率和效果，促进实现发展战略。由于内部控制存 在的固有局限性，故仅能为实现上述目标提供合理保证。此外，由于情况的变化 可能导致内部控制变得不恰当，或对控制政策和程序遵循 ...

证券代码：002141 证券简称：贤丰控股 公告编号：2024-034 贤丰控股股份有限公司 关于计提 2023 年度资产减值损失的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 2024 年 4 月 24 日贤丰控股股份有限公司（以下简称"公司"）第八届董事 会第五次会议、第八届监事会第三次会议审议通过了《关于计提 2023 年度资产 减值损失的议案》，同意公司依据《企业会计准则》等规定计提相关资产减值损 失 8,256.15 万元。现将具体情况公告如下： 注：上述数据已经审计，如存在合计尾差，属于四舍五入所致 二、本次计提资产减值损失的具体方法、依据 （一）应收账款、其他应收款 本次信用减值损失的计提依据《企业会计准则第 22 号——金融工具确认和 计量》进行处理。 一、本次计提资产减值损失情况概述 根据《企业会计准则》及《深圳证券交易所股票上市规则》等相关规定的要 求，为了更加真实、准确地反映公司的资产状况和财务状况，公司及下属子公司 对截止 2023 年 12 月 31 日的商誉、应收款项、应收票据、存货、合同资产等各 类资产进行了全面清查。根据 ...

证券代码：002141 证券简称：贤丰控股 公告编号：2024-025 贤丰控股股份有限公司 第八届董事会第五次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、董事会会议召开情况 1. 贤丰控股股份有限公司（以下简称"公司"）第八届董事会第五次会议通 知于 2024 年 4 月 19 日以电话、邮件等方式发出。 2. 会议于 2024 年 4 月 24 日在公司会议室以现场与通讯表决相结合的方式 召开。 3. 会议应参与表决董事 6 人，实际参与表决董事 6 人（其中：以通讯方式 出席会议的董事 1 人，为独立董事肖世练）。 4. 会议由公司董事长韩桃子女士主持，公司高级管理人员列席了会议。 5. 本次董事会会议的召开符合有关法律、行政法规、部门规章、规范性文 件和《公司章程》的规定。 二、董事会会议审议情况 1. 审议通过《2023 年度董事会工作报告》 表决结果：以 6 票赞成、0 票反对、0 票弃权的表决结果，通过本议案。 公司董事会就 2023 年度工作情况编制了董事会工作报告。具体内容详见与 本公告同日披露于巨潮资讯网（www.cn ...

证券代码：002141 证券简称：贤丰控股 公告编号：2024-033 贤丰控股股份有限公司 关于 2023 年度日常关联交易确认及 2024 年度日常关联交易 预计的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 一、日常关联交易基本情况 | 关联交易 | 关联人 | 关联交 | 实际发 生金额 | 预计金额 | 实际发生额占 同类业务比例 | 实际发生额与 预计金额差异 | 披露日期及 | | --- | --- | --- | --- | --- | --- | --- | --- | | 类别 | | 易内容 | （万元） | （万元） | （％） | （%） | 索引 | | 接受关联 | 丰盈基 | 基金管 | | | | | 2023/4/15 公告编号： | | 人提供的 | 金 | 理费用 | 429 | 500.00 | 100% | 14.2% | | | 劳务 | | | | | | | 2023-014 | | | 小计 | | 429 | 500.00 | 100% | 14.2% | | | | | | 公司董事会对日常关联 ...

[Important Notice](index=1&type=section&id=Important%20Notice) Management guarantees report accuracy and completeness; financial information is affirmed; this quarterly report is unaudited [Important Content Notice](index=1&type=section&id=Important%20Content%20Notice) Management guarantees report accuracy and completeness; financial information is affirmed; this quarterly report is unaudited - The board of directors, supervisory board, and senior management guarantee the truthfulness, accuracy, and completeness of the quarterly report, free from false records, misleading statements, or major omissions[2](index=2&type=chunk) - The company's principal, chief accountant, and head of accounting department declare the financial information in the quarterly report to be true, accurate, and complete[2](index=2&type=chunk) - This quarterly report is unaudited[3](index=3&type=chunk)[22](index=22&type=chunk) [Key Financial Data](index=1&type=section&id=Key%20Financial%20Data) Q1 2023 saw significant declines in revenue and net profit, negative operating cash flow, and notable balance sheet shifts [Key Accounting Data and Financial Indicators](index=1&type=section&id=Key%20Accounting%20Data%20and%20Financial%20Indicators) Q1 2023 saw significant declines in operating revenue and net profit, negative operating cash flow, and reduced EPS Key Accounting Data and Financial Indicators for Q1 2023 | Indicator | Current Period (CNY) | Prior Year Period (CNY) | Year-over-Year Change (%) | | :--- | :--- | :--- | :--- | | Operating Revenue | 20,891,494.35 | 274,449,534.28 | -92.39% | | Net Profit Attributable to Shareholders of the Listed Company | 1,281,203.21 | 17,608,180.89 | -92.72% | | Net Profit Attributable to Shareholders of the Listed Company (Excluding Non-recurring Gains/Losses) | -6,030,449.84 | -11,572,690.58 | 47.89% | | Net Cash Flow from Operating Activities | -6,182,905.64 | 7,385,550.42 | -183.72% | | Basic Earnings Per Share (CNY/share) | 0.0011 | 0.0155 | -92.90% | | Diluted Earnings Per Share (CNY/share) | 0.0011 | 0.0155 | -92.90% | | Weighted Average Return on Net Assets | 0.11% | 2.24% | -2.13% | | **Period-End Indicators** | **End of Current Period (CNY)** | **End of Prior Year (CNY)** | **Change from Prior Year-End (%)** | | Total Assets | 1,331,356,325.40 | 1,343,332,102.28 | -0.89% | | Total Equity Attributable to Shareholders of the Listed Company | 1,143,271,174.71 | 1,146,062,191.42 | -0.24% | [Non-recurring Gains and Losses Items and Amounts](index=1&type=section&id=Non-recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) Total non-recurring gains and losses were 7.31 million CNY, mainly from fair value changes in wealth management products Non-recurring Gains and Losses Items for Q1 2023 | Item | Amount for Current Period (CNY) | Explanation | | :--- | :--- | :--- | | Gains/Losses on Disposal of Non-current Assets | 2,477.88 | | | Gains/Losses from Changes in Fair Value of Financial Assets/Liabilities Held for Trading and Investment Income from Disposal | 7,362,341.90 | Primarily due to floating gains recognized from wealth management products held | | Other Non-operating Income and Expenses | -5,059.86 | | | Less: Income Tax Impact | 10,851.37 | | | Impact on Minority Interests (After Tax) | 37,255.50 | | | **Total** | **7,311,653.05** | | - The company has not classified any non-recurring gains and losses items listed in 'Interpretive Announcement No. 1 on Information Disclosure by Companies Issuing Securities to the Public – Non-recurring Gains and Losses' as recurring gains and losses[6](index=6&type=chunk) [Changes and Reasons for Key Accounting Data and Financial Indicators](index=2&type=section&id=Changes%20and%20Reasons%20for%20Key%20Accounting%20Data%20and%20Financial%20Indicators) Financial indicators changed significantly due to prior year's equity sale, increased fixed deposit interest, and wealth management gains Changes in Balance Sheet Items | Item | End of Current Period (CNY) | End of Prior Year (CNY) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Cash and Cash Equivalents | 154,449,777.08 | 222,035,405.67 | -30.44% | Primarily due to transfer of some fixed deposits to wealth management products | | Prepayments | 4,285,921.32 | 7,822,111.74 | -45.21% | Primarily due to subsidiary's prior prepayments for goods offsetting current period purchases | | Other Receivables | 1,591,256.70 | 1,024,505.53 | 55.32% | Primarily due to subsidiary increasing petty cash for business needs | | Non-current Assets Due Within One Year | 1,686,521.55 | 3,050,975.75 | -44.72% | Primarily due to normal collection from subsidiary's finance lease business | | Other Current Assets | 1,213,954.29 | 921,939.81 | 31.67% | Primarily due to increased prepaid expenses in the current period | | Contract Liabilities | 14,643,103.05 | 7,415,346.12 | 97.47% | Primarily due to increased customer prepayments for purchases in the current period | | Employee Benefits Payable | 4,180,994.31 | 11,435,440.53 | -63.44% | Primarily due to the company paying employee benefits accrued at the end of last year | | Taxes Payable | 662,471.86 | 1,875,000.65 | -64.67% | Primarily due to payment of prior period VAT | | Other Comprehensive Income | 3,064,044.60 | 7,136,264.52 | -57.06% | Primarily due to decrease in foreign currency translation of subsidiary's financial statements due to exchange rate fluctuations | Changes in Income Statement Items | Item | Current Period Amount (CNY) | Prior Year Period Amount (CNY) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue | 20,891,494.35 | 274,449,534.28 | -92.39% | Primarily due to the sale of Zhuhai Rongsheng Super Micro Wire Co., Ltd. equity in the prior year, thus current period data does not include Zhuhai Rongsheng's figures | | Operating Cost | 10,352,091.08 | 249,424,255.51 | -95.85% | Same as above | | Taxes and Surcharges | 466,085.92 | 1,116,432.69 | -58.25% | Same as above | | Selling Expenses | 4,047,132.32 | 7,488,013.89 | -45.95% | Same as above | | Administrative Expenses | 14,201,628.42 | 21,452,835.75 | -33.80% | Same as above | | R&D Expenses | 3,944,039.75 | 8,837,442.94 | -55.37% | Same as above | | Other Income | 139,450.36 | 792,414.78 | -82.40% | Same as above | | Asset Impairment Losses | 0.00 | 351,614.89 | -100.00% | Same as above | | Financial Expenses | -4,455,780.60 | 796,095.05 | -659.70% | Primarily due to increased fixed deposit interest and increased exchange gains on USD foreign debt held by the parent company due to a decrease in the USD to CNY exchange rate | | Investment Income | 1,253,041.70 | -1,761,248.19 | 171.15% | Primarily due to increased returns from wealth management products held and increased investment income from subsidiary's external equity investments | | Gains from Changes in Fair Value | 6,458,780.60 | 8,010.46 | 80529.33% | Primarily due to floating gains recognized from wealth management products held | Changes in Cash Flow Statement Items | Item | Current Period Amount (CNY) | Prior Year Period Amount (CNY) | Change (%) | Reason for Change | | :--- | :--- | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -6,182,905.64 | 7,385,550.42 | -183.72% | Primarily due to the sale of Zhuhai Rongsheng equity in the prior year, thus current period data does not include Zhuhai Rongsheng's figures | | Net Cash Flow from Investing Activities | -59,325,858.17 | 35,046,952.79 | -269.28% | Primarily due to idle funds being repeatedly invested in wealth management products in the current period | | Net Cash Flow from Financing Activities | -1,837,553.67 | -16,645,350.99 | 88.96% | Primarily due to no principal and interest payments for finance leases in the current period | [Shareholder Information](index=3&type=section&id=Shareholder%20Information) The company has many common shareholders; top two corporate entities hold significant, largely pledged and frozen, stakes [Total Number of Common Shareholders and Top Ten Shareholders' Shareholding](index=3&type=section&id=Total%20Number%20of%20Common%20Shareholders%20and%20Top%20Ten%20Shareholders'%20Shareholding) The company had 44,592 common shareholders; top two shareholders held over 40% of shares, mostly pledged and frozen - As of the end of the reporting period, the total number of common shareholders was **44,592**, with no preferred shareholders whose voting rights have been restored[9](index=9&type=chunk) Top 10 Shareholders' Shareholding | Shareholder Name | Shareholder Nature | Shareholding Ratio (%) | Number of Shares (shares) | Pledged, Frozen Status | | :--- | :--- | :--- | :--- | :--- | | Guangdong Xianfeng Holdings Co., Ltd. | Domestic Non-state-owned Legal Person | 26.03% | 295,358,647 | Pledged 292,200,000 shares, frozen 295,358,647 shares | | Xianfeng Holdings Group Co., Ltd. | Domestic Non-state-owned Legal Person | 14.03% | 159,152,000 | Pledged 114,000,000 shares, frozen 159,152,000 shares | | Dacheng Innovation Capital - China Merchants Bank - Boyuan Hengfeng Asset Management Plan | Other | 4.00% | 45,392,783 | None | | Southern Capital - Bank of Ningbo - Rongsheng Super Micro Private Placement No. 2 Special Asset Management Plan | Other | 3.01% | 34,143,710 | None | | Southern Capital - Bank of Ningbo - Liang Xiongjian | Other | 2.39% | 27,084,228 | None | | Xiao Qiaodang | Domestic Natural Person | 1.08% | 12,301,300 | None | | Huang Guoliang | Domestic Natural Person | 0.99% | 11,211,600 | None | | Shenzhen Yuntu Asset Management Service Co., Ltd. - Yuntu Premium No. 12 Private Securities Investment Fund | Other | 0.88% | 10,000,000 | None | | Shi Wen | Domestic Natural Person | 0.56% | 6,400,000 | None | | Zheshang Bank Co., Ltd. - Guotai CSI Livestock Breeding ETF | Other | 0.55% | 6,255,375 | None | - Guangdong Xianfeng Holdings Co., Ltd. is a wholly-owned subsidiary of Xianfeng Holdings Group Co., Ltd.; whether other shareholders have related party relationships or act in concert is unknown[9](index=9&type=chunk) - Shenzhen Yuntu Asset Management Service Co., Ltd. - Yuntu Premium No. 12 Private Securities Investment Fund and Shi Wen hold company shares through margin trading and securities lending accounts[10](index=10&type=chunk) [Total Number of Preferred Shareholders and Top 10 Preferred Shareholders' Shareholding](index=4&type=section&id=Total%20Number%20of%20Preferred%20Shareholders%20and%20Top%2010%20Preferred%20Shareholders'%20Shareholding) The company has no preferred shareholders - The company has no preferred shareholders[11](index=11&type=chunk) [Other Significant Matters](index=4&type=section&id=Other%20Significant%20Matters) Two important temporary reports were disclosed: a carbonated lithium extraction pilot project filing and private fund subscription [Other Significant Matters](index=4&type=section&id=Other%20Significant%20Matters) Two important temporary reports were disclosed: a carbonated lithium extraction pilot project filing and private fund subscription Important Temporary Reports Disclosed During the Reporting Period | Overview of Important Matter | Disclosure Date | Index for Temporary Report Disclosure Website Query | | :--- | :--- | :--- | | Announcement on Subsidiary's Carbonated Lithium Extraction Pilot Project Obtaining Filing Approval | 2023 年 01 月 04 日 | Juchao Information Network (www.cninfo.com.cn) | | Announcement on Subscribing to Private Securities Investment Fund Shares | 2023 年 03 月 17 日 | Juchao Information Network (www.cninfo.com.cn) | [Quarterly Financial Statements](index=4&type=section&id=Quarterly%20Financial%20Statements) The quarterly financial statements (balance sheet, income statement, cash flow) remain unaudited [Consolidated Balance Sheet](index=4&type=section&id=Consolidated%20Balance%20Sheet) Total assets were 1.33 billion CNY, slightly down from year-start, with increased financial assets and contract liabilities Key Consolidated Balance Sheet Data (March 31, 2023) | Item | Period-End Balance (CNY) | Beginning of Year Balance (CNY) | | :--- | :--- | :--- | | **Assets** | | | | Cash and Cash Equivalents | 154,449,777.08 | 222,035,405.67 | | Financial Assets Held for Trading | 506,076,313.10 | 447,650,904.02 | | Total Current Assets | 752,383,917.82 | 761,626,922.95 | | Total Non-current Assets | 578,972,407.58 | 581,705,179.33 | | **Total Assets** | **1,331,356,325.40** | **1,343,332,102.28** | | **Liabilities** | | | | Contract Liabilities | 14,643,103.05 | 7,415,346.12 | | Total Current Liabilities | 91,534,003.69 | 98,238,788.49 | | Total Non-current Liabilities | 24,730,328.97 | 26,165,005.00 | | **Total Liabilities** | **116,264,332.66** | **124,403,793.49** | | **Shareholders' Equity** | | | | Total Equity Attributable to Parent Company Shareholders | 1,143,271,174.71 | 1,146,062,191.42 | | Minority Interests | 71,820,818.03 | 72,866,117.37 | | **Total Shareholders' Equity** | **1,215,091,992.74** | **1,218,928,308.79** | [Consolidated Income Statement](index=6&type=section&id=Consolidated%20Income%20Statement) Q1 2023 saw significant declines in total operating revenue and net profit, with financial expenses turning negative and investment/fair value gains growing Key Consolidated Income Statement Data (January-March 2023) | Item | Current Period Amount (CNY) | Prior Period Amount (CNY) | | :--- | :--- | :--- | | Total Operating Revenue | 20,891,494.35 | 274,449,534.28 | | Total Operating Cost | 28,555,196.89 | 289,115,075.83 | | Financial Expenses | -4,455,780.60 | 796,095.05 | | Investment Income | 1,253,041.70 | -1,761,248.19 | | Gains from Changes in Fair Value | 6,458,780.60 | 8,010.46 | | Operating Profit | 182,673.85 | 14,034,809.02 | | Total Profit | 177,613.99 | 14,385,402.12 | | Net Profit | 235,903.87 | 15,563,776.00 | | Net Profit Attributable to Parent Company Shareholders | 1,281,203.21 | 17,608,180.89 | | Basic Earnings Per Share (CNY) | 0.0011 | 0.0155 | - Net profit from continuing operations was **235,903.87 CNY**, with net profit from discontinued operations at **0**[18](index=18&type=chunk) [Consolidated Cash Flow Statement](index=7&type=section&id=Consolidated%20Cash%20Flow%20Statement) Q1 2023 net cash flow from operating activities was -6.18 million CNY, investing activities -59.32 million CNY, and financing activities -1.83 million CNY Key Consolidated Cash Flow Statement Data (January-March 2023) | Item | Current Period Amount (CNY) | Prior Period Amount (CNY) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | -6,182,905.64 | 7,385,550.42 | | Net Cash Flow from Investing Activities | -59,325,858.17 | 35,046,952.79 | | Net Cash Flow from Financing Activities | -1,837,553.67 | -16,645,350.99 | | Net Increase in Cash and Cash Equivalents | -67,588,548.37 | 25,819,380.14 | | Beginning Balance of Cash and Cash Equivalents | 216,933,170.71 | 23,989,207.60 | - Cash received from sales of goods and rendering of services significantly decreased year-over-year, from **306 million CNY** to **31 million CNY**[19](index=19&type=chunk) - Cash received relating to other investing activities significantly increased, from **56.39 million CNY** to **267 million CNY**[20](index=20&type=chunk) [Audit Report](index=9&type=section&id=Audit%20Report) The company's Q1 2023 report is unaudited - The company's first quarter report is unaudited[22](index=22&type=chunk)

1. 公司本次对前期会计差错采用追溯重述法进行更正，相应对 2023 年第一 季度财务报表、2023 年半年度财务报表、2023 年前三季度财务报表进行追溯调 整，追溯调整后，不会导致公司上述报告期盈亏性质的改变。 2. 本次追溯调整事项给广大投资者造成的不便，公司深表歉意，今后公司 将持续提升治理水平和规范运作水平，努力提高信息披露质量，切实保障公司及 全体股东的利益。 证券代码：002141 证券简称：贤丰控股 公告编号：2024-032 贤丰控股股份有限公司 关于前期会计差错更正的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 贤丰控股股份有限公司（简称"公司"或"贤丰控股"）于 2024 年 4 月 24 日召开第八届董事会第五次会议和第八届监事会第三次会议，审议通过了《关于 前期会计差错更正的议案》。根据《企业会计准则第 28 号——会计政策、会计 估计和会计差错更正》《公开发行证券的公司信息披露编报规则第 19 号——财 务信息的更正及相关披露》的相关规定，公司前期会计差错更正具体情况如下： 一、前期会计差错事项更正原因及内容 1 ...

Financial Performance - Q3 2023 revenue decreased by 91.35% year-on-year to CNY 23,201,695.46, and year-to-date revenue decreased by 92.19% to CNY 67,702,677.80[3] - Net profit attributable to shareholders was a loss of CNY 9,357,556.47, down 104.15% year-on-year, with a year-to-date loss of CNY 33,047,731.81, down 113.29%[3] - Basic and diluted earnings per share were both CNY -0.0082, reflecting a decrease of 104.13% year-on-year[3] - Operating revenue for the first nine months of 2023 was CNY 67,702,677.80, a decrease of 92.19% compared to CNY 866,568,570.92 in the same period last year[9] - Operating costs decreased by 94.84% to CNY 40,396,627.87 from CNY 782,381,441.66 year-on-year[9] - The net profit for Q3 2023 was -38,739,295.44 CNY, compared to a net profit of 261,575,847.48 CNY in the same period last year, indicating a significant decline[19] - Operating profit for the quarter was -39,974,043.54 CNY, down from 256,895,299.02 CNY year-over-year[19] - Total comprehensive income for the quarter was -29,350,957.03 CNY, compared to 293,916,236.39 CNY in the same quarter last year[19] Assets and Liabilities - Total assets at the end of Q3 2023 were CNY 1,303,034,681.94, a decrease of 3.00% from the end of the previous year[3] - Total current assets decreased to ¥729,548,946.95 from ¥761,626,922.95, primarily due to a reduction in cash and cash equivalents[15] - The total liabilities decreased to ¥113,457,330.18 from ¥124,403,793.49, indicating a reduction of about 8.0%[16] - The company's total equity decreased to ¥1,189,577,351.76 from ¥1,218,928,308.79, reflecting a decline of approximately 2.4%[16] Cash Flow - Cash flow from operating activities was negative at CNY -52,538,970.53, representing a decline of 171.38% year-to-date[3] - Net cash flow from operating activities was CNY -52,538,970.53, a decline of 171.38% from CNY 73,602,875.23 in the same period last year[9] - Investment activities generated a net cash flow of CNY -92,280,198.93, down 119.08% from CNY 483,546,518.35 year-on-year[9] - The total cash outflow from investing activities was -92,280,198.93 CNY, compared to a net inflow of 483,546,518.35 CNY in the same period last year[21] - The company had a cash inflow from financing activities of 14,472,419.00 CNY, contrasting with a net outflow of -9,219,892.51 CNY in the previous year[21] Expenses - Research and development expenses fell by 72.66% to CNY 10,749,644.78 compared to CNY 39,316,154.20 in the previous year[9] - Financial expenses decreased by 76.41% to CNY 7,403,859.98 from CNY 31,379,221.85 in the previous year, mainly due to increased interest income from time deposits[9] Other Financial Metrics - Accounts receivable increased by 44.27% to CNY 33,551,694.66, primarily due to increased business from a subsidiary[8] - Inventory rose by 44.25% to CNY 43,811,884.73, mainly due to stock purchases by a subsidiary[8] - The company reported a significant increase in other receivables, up 333.79% to CNY 4,444,207.38, due to increased cash reserves for business needs[8] - The company reported a significant decrease in investment income, down 99.05% to CNY 2,575,194.61 from CNY 270,898,815.74, attributed to the previous year's gain from the sale of equity in Zhuhai Rongsheng[9] - Other comprehensive income increased by 131.56% to CNY 16,524,602.93, primarily due to foreign currency translation adjustments from the subsidiary in Hong Kong[9] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 45,146[10] - The company announced plans for capital increase in its controlling subsidiary and the establishment of a controlling grandchild company on August 3, 2023[12] Audit Information - The company did not conduct an audit for the Q3 report[23]